| David Charles Nagel, MD | |
|
606 24th Ave S, Suite 700, Minneapolis, MN 55454-1455 | |
| (612) 672-2450 | |
| Not Available |
| Full Name | David Charles Nagel |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 606 24th Ave S, Minneapolis, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023083805 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 47999 (Minnesota) | Primary |
| Entity Name | Grand Itasca Clinic And Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669426631 PECOS PAC ID: 8123939550 Enrollment ID: O20031105000209 |
News Archive
Initial findings reported by the Arizona COVID-19 Genomics Union (ACGU) suggest that following Arizona's first reported case of COVID-19 in late January, the state experienced no cases that went undetected and was COVID-free until at least 11 distinct incursions occurred between mid-February and early April.
The Autism Speaks Autism Treatment Network (ATN), has received a $12 million federal grant to continue to serve as the Autism Intervention Research Network on Physical Health.
At the Organization of Human Brain Mapping's 16th Annual Meeting (Barcelona, Spain, June 6-10), Elekta unveiled its next generation magnetoencephalography system, Elekta Neuromag TRIUX. A platform that addresses key requirements critical for monitoring normal and abnormal brain activity, Elekta Neuromag TRIUX was designed to operate in virtually any clinical environment – an advance welcomed by the growing number of Elekta Neuromag clinical and research facilities worldwide.
Chiasma, Inc., a privately held biopharma company, announced today that it has granted Novartis an option to obtain exclusive worldwide rights to develop and commercialize the Company's Transient Permeability Enhancer (TPE) technology for use with certain related small molecule products either in development or currently marketed by Novartis.
› Verified 9 days ago
| Entity Name | Range Regional Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669569265 PECOS PAC ID: 8022920024 Enrollment ID: O20031110000095 |
News Archive
Initial findings reported by the Arizona COVID-19 Genomics Union (ACGU) suggest that following Arizona's first reported case of COVID-19 in late January, the state experienced no cases that went undetected and was COVID-free until at least 11 distinct incursions occurred between mid-February and early April.
The Autism Speaks Autism Treatment Network (ATN), has received a $12 million federal grant to continue to serve as the Autism Intervention Research Network on Physical Health.
At the Organization of Human Brain Mapping's 16th Annual Meeting (Barcelona, Spain, June 6-10), Elekta unveiled its next generation magnetoencephalography system, Elekta Neuromag TRIUX. A platform that addresses key requirements critical for monitoring normal and abnormal brain activity, Elekta Neuromag TRIUX was designed to operate in virtually any clinical environment – an advance welcomed by the growing number of Elekta Neuromag clinical and research facilities worldwide.
Chiasma, Inc., a privately held biopharma company, announced today that it has granted Novartis an option to obtain exclusive worldwide rights to develop and commercialize the Company's Transient Permeability Enhancer (TPE) technology for use with certain related small molecule products either in development or currently marketed by Novartis.
› Verified 9 days ago
| Entity Name | St Lukes Hospital Of Duluth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902845068 PECOS PAC ID: 7113834839 Enrollment ID: O20031120000212 |
News Archive
Initial findings reported by the Arizona COVID-19 Genomics Union (ACGU) suggest that following Arizona's first reported case of COVID-19 in late January, the state experienced no cases that went undetected and was COVID-free until at least 11 distinct incursions occurred between mid-February and early April.
The Autism Speaks Autism Treatment Network (ATN), has received a $12 million federal grant to continue to serve as the Autism Intervention Research Network on Physical Health.
At the Organization of Human Brain Mapping's 16th Annual Meeting (Barcelona, Spain, June 6-10), Elekta unveiled its next generation magnetoencephalography system, Elekta Neuromag TRIUX. A platform that addresses key requirements critical for monitoring normal and abnormal brain activity, Elekta Neuromag TRIUX was designed to operate in virtually any clinical environment – an advance welcomed by the growing number of Elekta Neuromag clinical and research facilities worldwide.
Chiasma, Inc., a privately held biopharma company, announced today that it has granted Novartis an option to obtain exclusive worldwide rights to develop and commercialize the Company's Transient Permeability Enhancer (TPE) technology for use with certain related small molecule products either in development or currently marketed by Novartis.
› Verified 9 days ago
| Entity Name | Astera Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134305162 PECOS PAC ID: 2961395272 Enrollment ID: O20040202001082 |
News Archive
Initial findings reported by the Arizona COVID-19 Genomics Union (ACGU) suggest that following Arizona's first reported case of COVID-19 in late January, the state experienced no cases that went undetected and was COVID-free until at least 11 distinct incursions occurred between mid-February and early April.
The Autism Speaks Autism Treatment Network (ATN), has received a $12 million federal grant to continue to serve as the Autism Intervention Research Network on Physical Health.
At the Organization of Human Brain Mapping's 16th Annual Meeting (Barcelona, Spain, June 6-10), Elekta unveiled its next generation magnetoencephalography system, Elekta Neuromag TRIUX. A platform that addresses key requirements critical for monitoring normal and abnormal brain activity, Elekta Neuromag TRIUX was designed to operate in virtually any clinical environment – an advance welcomed by the growing number of Elekta Neuromag clinical and research facilities worldwide.
Chiasma, Inc., a privately held biopharma company, announced today that it has granted Novartis an option to obtain exclusive worldwide rights to develop and commercialize the Company's Transient Permeability Enhancer (TPE) technology for use with certain related small molecule products either in development or currently marketed by Novartis.
› Verified 9 days ago
| Entity Name | Astera Health |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1477545333 PECOS PAC ID: 2961395272 Enrollment ID: O20060504000722 |
News Archive
Initial findings reported by the Arizona COVID-19 Genomics Union (ACGU) suggest that following Arizona's first reported case of COVID-19 in late January, the state experienced no cases that went undetected and was COVID-free until at least 11 distinct incursions occurred between mid-February and early April.
The Autism Speaks Autism Treatment Network (ATN), has received a $12 million federal grant to continue to serve as the Autism Intervention Research Network on Physical Health.
At the Organization of Human Brain Mapping's 16th Annual Meeting (Barcelona, Spain, June 6-10), Elekta unveiled its next generation magnetoencephalography system, Elekta Neuromag TRIUX. A platform that addresses key requirements critical for monitoring normal and abnormal brain activity, Elekta Neuromag TRIUX was designed to operate in virtually any clinical environment – an advance welcomed by the growing number of Elekta Neuromag clinical and research facilities worldwide.
Chiasma, Inc., a privately held biopharma company, announced today that it has granted Novartis an option to obtain exclusive worldwide rights to develop and commercialize the Company's Transient Permeability Enhancer (TPE) technology for use with certain related small molecule products either in development or currently marketed by Novartis.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Charles Nagel, MD 606 24th Ave S, Suite 700, Minneapolis, MN 55454-1455 Ph: (612) 672-2450 | David Charles Nagel, MD 606 24th Ave S, Suite 700, Minneapolis, MN 55454-1455 Ph: (612) 672-2450 |
News Archive
Initial findings reported by the Arizona COVID-19 Genomics Union (ACGU) suggest that following Arizona's first reported case of COVID-19 in late January, the state experienced no cases that went undetected and was COVID-free until at least 11 distinct incursions occurred between mid-February and early April.
The Autism Speaks Autism Treatment Network (ATN), has received a $12 million federal grant to continue to serve as the Autism Intervention Research Network on Physical Health.
At the Organization of Human Brain Mapping's 16th Annual Meeting (Barcelona, Spain, June 6-10), Elekta unveiled its next generation magnetoencephalography system, Elekta Neuromag TRIUX. A platform that addresses key requirements critical for monitoring normal and abnormal brain activity, Elekta Neuromag TRIUX was designed to operate in virtually any clinical environment – an advance welcomed by the growing number of Elekta Neuromag clinical and research facilities worldwide.
Chiasma, Inc., a privately held biopharma company, announced today that it has granted Novartis an option to obtain exclusive worldwide rights to develop and commercialize the Company's Transient Permeability Enhancer (TPE) technology for use with certain related small molecule products either in development or currently marketed by Novartis.
› Verified 9 days ago
Jessica L Nyholm, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 606 24th Ave S, Suite 400, Minneapolis, MN 55454 Phone: 612-273-2223 | |
Mr. Clifton O Brock, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 902 E 26th St Ste 1700, Minneapolis, MN 55404 Phone: 612-863-4502 | |
John W Hering, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2220 Riverside Ave, Mail Stop 31700a, Minneapolis, MN 55454 Phone: 612-371-1600 Fax: 612-371-1732 | |
Marilyn Susan Joseph, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 410 Church St Se, Boynton Health Service, Minneapolis, MN 55455 Phone: 612-625-5187 Fax: 612-625-0902 | |
Dr. Jennifer Martha Mckeand, MD MS Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 121 South 8th St Suite 600, Womens Health Consultants, Minneapolis, MN 55402 Phone: 612-333-4822 Fax: 612-333-3108 | |
Dr. Amanda Leigh Boozalis, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3270 W Lake St, Minneapolis, MN 55416 Phone: 612-775-1800 Fax: 612-775-1805 |